In a transgenic mouse model, Sun [23] has evaluated the role that mTOR plays in anal carcinogenesis, finding that mTOR knockout led to a delay in carcinoma onset, and thus suggesting this as a potential therapeutic target, too. Here, MTOR is linked to carcinoma.